Elemental Therapeutics

At Elemental Therapeutics, we’re on a mission to restore the efficacy of antibiotics against drug-resistant infections. We’re developing a small molecule therapeutic, called PBT2, for treatment of community-acquired bacterial pneumonia (CABP). PBT2 is safe, low cost, orally bioavailable and has shown no development of resistance. Connect with us to help get PBT2 to the patients that need it and ensure antibiotics work first time, every time. 

Elemental Therapeutics is a pre-incorporated preclinical stage biotechnology company. 

Seeking: Investment for preclinical development and mentors with commercial expertise 

Interested in connecting? Check out the Elemental Therapeutics website or ask the ON team via ON@csiro.au to facilitate a connection with us.

Meet the team